Featured
FDA drug dosage optimisation guidelines signal clinical trial reform
In January, amidst calls to improve patient safety by optimizing licensed drug formulations, the FDA released a draft guidance that…
FDA suggests ways to curb constraints with rare disease gene therapy trials
On February 7, at a town hall organised to discuss clinical trial designs for gene therapies, FDA experts pushed pharma…
Japan accounts for 4.7% share of global clinical trial activity in 2022
Japan has accounted for a 4.7% share of the global clinical trials activity in 2022, registering a decrease when compared…
China accounts for 27.7% share of global clinical trial activity in 2022
China has accounted for a 27.7% share of the global clinical trials activity in 2022, registering an increase when compared…
US accounts for 18.4% share of global clinical trial activity in 2022
The US has accounted for an 18.4% share of the global clinical trials activity in 2022, registering a decrease when…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Global clinical trials activity decreases 1.8% in Q4 2022 over 4Q average
The global clinical trials activity saw a decrease of 1.8% in Q4 2022, when compared with the rolling average of…
Global clinical trials activity decreases 8.8% YoY in Q4 2022
Global clinical trials activity decreased by 8.8% in Q4 2022, when compared with the same quarter in 2021, according to…
Human Immunodeficiency Virus (HIV) Infections (AIDS) accounts for 6.3% share of global Infectious Disease clinical trial activity in 2021
Human Immunodeficiency Virus (HIV) Infections (AIDS) accounted for a 6.3% share of the global clinical trials within the Infectious Disease…